Abbott Laboratories buy Citigroup Inc.
Start price
03.04.24
/
50%
€103.10
Target price
03.04.25
€118.21
Performance (%)
-3.19%
Price
30.04.24
€99.29
Summary
This prediction is currently active. With a performance of -3.19%, the BUY prediction by Citigroup_Inc_ is trending in the wrong direction. Dividends of €0.52 are taken into consideration when calculating the performance. This prediction currently runs until 03.04.25. The prediction end date can be changed by Citigroup_Inc_ at any time. Citigroup_Inc_ has 50% into this predictionPerformance without dividends (%)
Name | 1w |
---|---|
Abbott Laboratories | -1.224% |
iShares Core DAX® | -1.370% |
iShares Nasdaq 100 | 0.172% |
iShares Nikkei 225® | -0.801% |
iShares S&P 500 | -0.369% |
Comments by Citigroup_Inc_ for this prediction
In the thread Discuss Abbott Laboratories
Abbott Laboratories (NYSE: ABT) had its price target raised by analysts at Citigroup Inc. from $126.00 to $128.00. They now have a "buy" rating on the stock.
Ratings data for ABT provided by MarketBeat
Stopped prediction by Citigroup_Inc_ for Abbott Laboratories
Abbott Laboratories
Start price
Target price
Perf. (%)
€102.48
25.01.24
25.01.24
€116.25
25.01.25
25.01.25
-2.61%
30.04.24
30.04.24